nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—MPO—Alzheimer's disease	0.351	0.493	CbGaD
Aminosalicylic Acid—PTGS1—Alzheimer's disease	0.23	0.323	CbGaD
Aminosalicylic Acid—PTGS2—Alzheimer's disease	0.132	0.185	CbGaD
Aminosalicylic Acid—Cutaneous hypersensitivity—Rivastigmine—Alzheimer's disease	0.00655	0.0536	CcSEcCtD
Aminosalicylic Acid—Non-Hodgkin's lymphoma—Memantine—Alzheimer's disease	0.00468	0.0383	CcSEcCtD
Aminosalicylic Acid—Lymphoma—Memantine—Alzheimer's disease	0.00468	0.0383	CcSEcCtD
Aminosalicylic Acid—Abdominal bloating—Donepezil—Alzheimer's disease	0.00378	0.0309	CcSEcCtD
Aminosalicylic Acid—Diflunisal—TTR—Alzheimer's disease	0.00299	0.497	CrCbGaD
Aminosalicylic Acid—Hypothyroidism—Memantine—Alzheimer's disease	0.00254	0.0208	CcSEcCtD
Aminosalicylic Acid—Encephalopathy—Memantine—Alzheimer's disease	0.00254	0.0208	CcSEcCtD
Aminosalicylic Acid—Hypothyroidism—Rivastigmine—Alzheimer's disease	0.00249	0.0204	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Rivastigmine—Alzheimer's disease	0.00239	0.0196	CcSEcCtD
Aminosalicylic Acid—MPO—blood vessel—Alzheimer's disease	0.00217	0.132	CbGeAlD
Aminosalicylic Acid—Dermatitis atopic—Rivastigmine—Alzheimer's disease	0.00216	0.0177	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Galantamine—Alzheimer's disease	0.00188	0.0154	CcSEcCtD
Aminosalicylic Acid—Purpura—Galantamine—Alzheimer's disease	0.00175	0.0143	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Rivastigmine—Alzheimer's disease	0.00164	0.0134	CcSEcCtD
Aminosalicylic Acid—Haemolytic anaemia—Donepezil—Alzheimer's disease	0.00145	0.0118	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Donepezil—Alzheimer's disease	0.00134	0.011	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Memantine—Alzheimer's disease	0.00133	0.0109	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Galantamine—Alzheimer's disease	0.00132	0.0108	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.00131	0.0107	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Rivastigmine—Alzheimer's disease	0.0013	0.0106	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.00127	0.0104	CcSEcCtD
Aminosalicylic Acid—Purpura—Memantine—Alzheimer's disease	0.00123	0.0101	CcSEcCtD
Aminosalicylic Acid—CHUK—cerebellum—Alzheimer's disease	0.00123	0.0748	CbGeAlD
Aminosalicylic Acid—Hypoglycaemia—Memantine—Alzheimer's disease	0.00122	0.00995	CcSEcCtD
Aminosalicylic Acid—Purpura—Rivastigmine—Alzheimer's disease	0.0012	0.00985	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.00119	0.00973	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.00119	0.00971	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Galantamine—Alzheimer's disease	0.00117	0.00955	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.00116	0.0095	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00115	0.00943	CcSEcCtD
Aminosalicylic Acid—MPO—forebrain—Alzheimer's disease	0.00115	0.0698	CbGeAlD
Aminosalicylic Acid—Urethral disorder—Galantamine—Alzheimer's disease	0.00114	0.00936	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Donepezil—Alzheimer's disease	0.00114	0.0093	CcSEcCtD
Aminosalicylic Acid—PTGS1—blood vessel—Alzheimer's disease	0.00103	0.0627	CbGeAlD
Aminosalicylic Acid—Weight decreased—Donepezil—Alzheimer's disease	0.00102	0.00836	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Galantamine—Alzheimer's disease	0.00101	0.00831	CcSEcCtD
Aminosalicylic Acid—Flatulence—Galantamine—Alzheimer's disease	0.001	0.00819	CcSEcCtD
Aminosalicylic Acid—CHUK—brain—Alzheimer's disease	0.000998	0.0607	CbGeAlD
Aminosalicylic Acid—Dysgeusia—Galantamine—Alzheimer's disease	0.000994	0.00814	CcSEcCtD
Aminosalicylic Acid—PTGS2—blood vessel—Alzheimer's disease	0.000985	0.06	CbGeAlD
Aminosalicylic Acid—Jaundice—Donepezil—Alzheimer's disease	0.000981	0.00803	CcSEcCtD
Aminosalicylic Acid—Anaemia—Galantamine—Alzheimer's disease	0.000938	0.00768	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Memantine—Alzheimer's disease	0.000927	0.00759	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Rivastigmine—Alzheimer's disease	0.000907	0.00743	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Donepezil—Alzheimer's disease	0.000903	0.0074	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000896	0.00733	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000892	0.00731	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Donepezil—Alzheimer's disease	0.000886	0.00725	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000876	0.00717	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000858	0.00703	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Memantine—Alzheimer's disease	0.000853	0.00698	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Memantine—Alzheimer's disease	0.00082	0.00672	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Galantamine—Alzheimer's disease	0.000812	0.00665	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000811	0.00664	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Memantine—Alzheimer's disease	0.00081	0.00663	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Galantamine—Alzheimer's disease	0.000805	0.00659	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Memantine—Alzheimer's disease	0.000804	0.00658	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Rivastigmine—Alzheimer's disease	0.000803	0.00657	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000793	0.00649	CcSEcCtD
Aminosalicylic Acid—Anorexia—Galantamine—Alzheimer's disease	0.000789	0.00646	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000787	0.00644	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Donepezil—Alzheimer's disease	0.000786	0.00644	CcSEcCtD
Aminosalicylic Acid—Flatulence—Donepezil—Alzheimer's disease	0.000775	0.00635	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Donepezil—Alzheimer's disease	0.00077	0.00631	CcSEcCtD
Aminosalicylic Acid—ALOX5—nervous system—Alzheimer's disease	0.000736	0.0448	CbGeAlD
Aminosalicylic Acid—Anaemia—Donepezil—Alzheimer's disease	0.000727	0.00595	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Galantamine—Alzheimer's disease	0.00072	0.0059	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000715	0.00585	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Memantine—Alzheimer's disease	0.000714	0.00585	CcSEcCtD
Aminosalicylic Acid—ALOX5—central nervous system—Alzheimer's disease	0.000708	0.0431	CbGeAlD
Aminosalicylic Acid—Flatulence—Memantine—Alzheimer's disease	0.000704	0.00576	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Memantine—Alzheimer's disease	0.000699	0.00573	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Rivastigmine—Alzheimer's disease	0.000699	0.00572	CcSEcCtD
Aminosalicylic Acid—ALOX5—cerebellum—Alzheimer's disease	0.000692	0.0421	CbGeAlD
Aminosalicylic Acid—Flatulence—Rivastigmine—Alzheimer's disease	0.000688	0.00564	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000684	0.0056	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000677	0.00555	CcSEcCtD
Aminosalicylic Acid—Anaemia—Memantine—Alzheimer's disease	0.00066	0.0054	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Galantamine—Alzheimer's disease	0.000655	0.00536	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Galantamine—Alzheimer's disease	0.000655	0.00536	CcSEcCtD
Aminosalicylic Acid—Anaemia—Rivastigmine—Alzheimer's disease	0.000646	0.00529	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Memantine—Alzheimer's disease	0.000639	0.00523	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Donepezil—Alzheimer's disease	0.000629	0.00515	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000628	0.00515	CcSEcCtD
Aminosalicylic Acid—MPO—nervous system—Alzheimer's disease	0.000622	0.0379	CbGeAlD
Aminosalicylic Acid—Anorexia—Donepezil—Alzheimer's disease	0.000612	0.00501	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Galantamine—Alzheimer's disease	0.00061	0.005	CcSEcCtD
Aminosalicylic Acid—MPO—central nervous system—Alzheimer's disease	0.000599	0.0365	CbGeAlD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000591	0.00484	CcSEcCtD
Aminosalicylic Acid—PTGS2—embryo—Alzheimer's disease	0.000588	0.0358	CbGeAlD
Aminosalicylic Acid—Mesalazine—MPO—Alzheimer's disease	0.000577	0.0959	CrCbGaD
Aminosalicylic Acid—Nervous system disorder—Memantine—Alzheimer's disease	0.000572	0.00468	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Memantine—Alzheimer's disease	0.000571	0.00467	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Galantamine—Alzheimer's disease	0.000567	0.00464	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Memantine—Alzheimer's disease	0.000566	0.00464	CcSEcCtD
Aminosalicylic Acid—ALOX5—brain—Alzheimer's disease	0.000562	0.0342	CbGeAlD
Aminosalicylic Acid—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000559	0.00458	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000558	0.00457	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Donepezil—Alzheimer's disease	0.000558	0.00457	CcSEcCtD
Aminosalicylic Acid—Anorexia—Memantine—Alzheimer's disease	0.000556	0.00455	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000554	0.00454	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Rivastigmine—Alzheimer's disease	0.000554	0.00453	CcSEcCtD
Aminosalicylic Acid—Dizziness—Galantamine—Alzheimer's disease	0.000548	0.00448	CcSEcCtD
Aminosalicylic Acid—PTGS1—forebrain—Alzheimer's disease	0.000544	0.0331	CbGeAlD
Aminosalicylic Acid—Anorexia—Rivastigmine—Alzheimer's disease	0.000543	0.00445	CcSEcCtD
Aminosalicylic Acid—Vomiting—Galantamine—Alzheimer's disease	0.000527	0.00431	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000525	0.0043	CcSEcCtD
Aminosalicylic Acid—Rash—Galantamine—Alzheimer's disease	0.000522	0.00428	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Galantamine—Alzheimer's disease	0.000522	0.00427	CcSEcCtD
Aminosalicylic Acid—PTGS2—forebrain—Alzheimer's disease	0.00052	0.0316	CbGeAlD
Aminosalicylic Acid—Headache—Galantamine—Alzheimer's disease	0.000519	0.00425	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PPARG—Alzheimer's disease	0.000512	0.0851	CrCbGaD
Aminosalicylic Acid—Urticaria—Donepezil—Alzheimer's disease	0.00051	0.00418	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Donepezil—Alzheimer's disease	0.000507	0.00415	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Donepezil—Alzheimer's disease	0.000507	0.00415	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Memantine—Alzheimer's disease	0.000507	0.00415	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000503	0.00412	CcSEcCtD
Aminosalicylic Acid—PTGS1—telencephalon—Alzheimer's disease	0.0005	0.0304	CbGeAlD
Aminosalicylic Acid—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000496	0.00406	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000492	0.00403	CcSEcCtD
Aminosalicylic Acid—Nausea—Galantamine—Alzheimer's disease	0.000492	0.00403	CcSEcCtD
Aminosalicylic Acid—Diflunisal—PTGS1—Alzheimer's disease	0.000482	0.0801	CrCbGaD
Aminosalicylic Acid—PTGS2—telencephalon—Alzheimer's disease	0.000478	0.0291	CbGeAlD
Aminosalicylic Acid—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000477	0.0039	CcSEcCtD
Aminosalicylic Acid—MPO—brain—Alzheimer's disease	0.000476	0.029	CbGeAlD
Aminosalicylic Acid—Hypersensitivity—Donepezil—Alzheimer's disease	0.000473	0.00387	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000466	0.00382	CcSEcCtD
Aminosalicylic Acid—Urticaria—Memantine—Alzheimer's disease	0.000463	0.00379	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Memantine—Alzheimer's disease	0.000461	0.00377	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Memantine—Alzheimer's disease	0.000461	0.00377	CcSEcCtD
Aminosalicylic Acid—Urticaria—Rivastigmine—Alzheimer's disease	0.000453	0.00371	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000451	0.00369	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000451	0.00369	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Donepezil—Alzheimer's disease	0.000439	0.0036	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Memantine—Alzheimer's disease	0.000429	0.00352	CcSEcCtD
Aminosalicylic Acid—Dizziness—Donepezil—Alzheimer's disease	0.000424	0.00348	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00042	0.00344	CcSEcCtD
Aminosalicylic Acid—Vomiting—Donepezil—Alzheimer's disease	0.000408	0.00334	CcSEcCtD
Aminosalicylic Acid—Rash—Donepezil—Alzheimer's disease	0.000405	0.00331	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Donepezil—Alzheimer's disease	0.000404	0.00331	CcSEcCtD
Aminosalicylic Acid—Headache—Donepezil—Alzheimer's disease	0.000402	0.00329	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Memantine—Alzheimer's disease	0.000399	0.00326	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00039	0.00319	CcSEcCtD
Aminosalicylic Acid—Dizziness—Memantine—Alzheimer's disease	0.000385	0.00316	CcSEcCtD
Aminosalicylic Acid—Nausea—Donepezil—Alzheimer's disease	0.000381	0.00312	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PTGS1—Alzheimer's disease	0.000378	0.0629	CrCbGaD
Aminosalicylic Acid—Dizziness—Rivastigmine—Alzheimer's disease	0.000377	0.00309	CcSEcCtD
Aminosalicylic Acid—Vomiting—Memantine—Alzheimer's disease	0.000371	0.00303	CcSEcCtD
Aminosalicylic Acid—Rash—Memantine—Alzheimer's disease	0.000367	0.00301	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Memantine—Alzheimer's disease	0.000367	0.00301	CcSEcCtD
Aminosalicylic Acid—Headache—Memantine—Alzheimer's disease	0.000365	0.00299	CcSEcCtD
Aminosalicylic Acid—Vomiting—Rivastigmine—Alzheimer's disease	0.000363	0.00297	CcSEcCtD
Aminosalicylic Acid—Rash—Rivastigmine—Alzheimer's disease	0.000359	0.00294	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Rivastigmine—Alzheimer's disease	0.000359	0.00294	CcSEcCtD
Aminosalicylic Acid—Headache—Rivastigmine—Alzheimer's disease	0.000357	0.00292	CcSEcCtD
Aminosalicylic Acid—Nausea—Memantine—Alzheimer's disease	0.000346	0.00283	CcSEcCtD
Aminosalicylic Acid—Nausea—Rivastigmine—Alzheimer's disease	0.000339	0.00277	CcSEcCtD
Aminosalicylic Acid—PTGS1—nervous system—Alzheimer's disease	0.000295	0.018	CbGeAlD
Aminosalicylic Acid—PTGS1—central nervous system—Alzheimer's disease	0.000284	0.0173	CbGeAlD
Aminosalicylic Acid—PTGS2—nervous system—Alzheimer's disease	0.000282	0.0172	CbGeAlD
Aminosalicylic Acid—Diflunisal—PTGS2—Alzheimer's disease	0.000276	0.0458	CrCbGaD
Aminosalicylic Acid—PTGS2—central nervous system—Alzheimer's disease	0.000272	0.0165	CbGeAlD
Aminosalicylic Acid—Salicylic acid—PTGS1—Alzheimer's disease	0.000268	0.0446	CrCbGaD
Aminosalicylic Acid—PTGS2—cerebellum—Alzheimer's disease	0.000266	0.0162	CbGeAlD
Aminosalicylic Acid—PTGS1—brain—Alzheimer's disease	0.000226	0.0137	CbGeAlD
Aminosalicylic Acid—Mesalazine—PTGS2—Alzheimer's disease	0.000216	0.0359	CrCbGaD
Aminosalicylic Acid—PTGS2—brain—Alzheimer's disease	0.000216	0.0131	CbGeAlD
Aminosalicylic Acid—L-DOPA—CYP2D6—Alzheimer's disease	0.000163	0.0272	CrCbGaD
Aminosalicylic Acid—Salicylic acid—PTGS2—Alzheimer's disease	0.000153	0.0255	CrCbGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PSENEN—Alzheimer's disease	2.91e-05	0.000205	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTK2B—Alzheimer's disease	2.9e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—IL6—Alzheimer's disease	2.9e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ND1—Alzheimer's disease	2.9e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—AKT1—Alzheimer's disease	2.89e-05	0.000203	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PPARGC1A—Alzheimer's disease	2.89e-05	0.000203	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—HMOX1—Alzheimer's disease	2.87e-05	0.000202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APH1A—Alzheimer's disease	2.87e-05	0.000202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	2.86e-05	0.000201	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CALM1—Alzheimer's disease	2.85e-05	0.000201	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—AKT1—Alzheimer's disease	2.85e-05	0.0002	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.83e-05	0.000199	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL6—Alzheimer's disease	2.83e-05	0.000199	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—GAB2—Alzheimer's disease	2.83e-05	0.000199	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.81e-05	0.000198	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.81e-05	0.000198	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—GSK3A—Alzheimer's disease	2.8e-05	0.000197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NCSTN—Alzheimer's disease	2.8e-05	0.000197	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—Alzheimer's disease	2.77e-05	0.000195	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SNCA—Alzheimer's disease	2.77e-05	0.000194	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—APP—Alzheimer's disease	2.75e-05	0.000194	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CALM1—Alzheimer's disease	2.74e-05	0.000193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ENO1—Alzheimer's disease	2.73e-05	0.000192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—Alzheimer's disease	2.73e-05	0.000192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—IL6—Alzheimer's disease	2.73e-05	0.000192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—IL6—Alzheimer's disease	2.73e-05	0.000192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LRP1—Alzheimer's disease	2.73e-05	0.000192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PPP3CA—Alzheimer's disease	2.72e-05	0.000191	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—AKT1—Alzheimer's disease	2.72e-05	0.000191	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—IL6—Alzheimer's disease	2.71e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—AKT1—Alzheimer's disease	2.71e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—AKT1—Alzheimer's disease	2.69e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—IL6—Alzheimer's disease	2.68e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—AKT1—Alzheimer's disease	2.68e-05	0.000188	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—IL6—Alzheimer's disease	2.67e-05	0.000188	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GAL—Alzheimer's disease	2.66e-05	0.000187	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GFAP—Alzheimer's disease	2.66e-05	0.000187	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—Alzheimer's disease	2.64e-05	0.000186	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—LPL—Alzheimer's disease	2.63e-05	0.000185	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—GAB2—Alzheimer's disease	2.61e-05	0.000183	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	2.59e-05	0.000182	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.59e-05	0.000182	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—GSK3A—Alzheimer's disease	2.59e-05	0.000182	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.56e-05	0.00018	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APP—Alzheimer's disease	2.54e-05	0.000179	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—Alzheimer's disease	2.52e-05	0.000177	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—AKT1—Alzheimer's disease	2.52e-05	0.000177	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—AKT1—Alzheimer's disease	2.52e-05	0.000177	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—AKT1—Alzheimer's disease	2.5e-05	0.000176	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—AKT1—Alzheimer's disease	2.48e-05	0.000174	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—AKT1—Alzheimer's disease	2.46e-05	0.000173	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PSENEN—Alzheimer's disease	2.46e-05	0.000173	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—GSK3B—Alzheimer's disease	2.46e-05	0.000173	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—Alzheimer's disease	2.45e-05	0.000172	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CREB1—Alzheimer's disease	2.44e-05	0.000172	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APH1A—Alzheimer's disease	2.43e-05	0.000171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—Alzheimer's disease	2.42e-05	0.00017	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	2.38e-05	0.000168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.37e-05	0.000167	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—MTHFR—Alzheimer's disease	2.37e-05	0.000166	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NCSTN—Alzheimer's disease	2.37e-05	0.000166	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—GSK3B—Alzheimer's disease	2.36e-05	0.000166	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TPI1—Alzheimer's disease	2.35e-05	0.000165	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CHAT—Alzheimer's disease	2.35e-05	0.000165	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—A2M—Alzheimer's disease	2.35e-05	0.000165	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CREB1—Alzheimer's disease	2.35e-05	0.000165	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—AKT1—Alzheimer's disease	2.33e-05	0.000164	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—LRP1—Alzheimer's disease	2.31e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PSEN2—Alzheimer's disease	2.27e-05	0.00016	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MAOB—Alzheimer's disease	2.25e-05	0.000159	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—S100B—Alzheimer's disease	2.24e-05	0.000157	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL6—Alzheimer's disease	2.24e-05	0.000157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—Alzheimer's disease	2.23e-05	0.000157	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.23e-05	0.000157	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TPI1—Alzheimer's disease	2.23e-05	0.000157	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CALM1—Alzheimer's disease	2.21e-05	0.000156	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—APOE—Alzheimer's disease	2.2e-05	0.000155	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.2e-05	0.000155	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ADAM10—Alzheimer's disease	2.19e-05	0.000154	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CAV1—Alzheimer's disease	2.18e-05	0.000154	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GAPDH—Alzheimer's disease	2.17e-05	0.000153	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.15e-05	0.000151	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.13e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—A2M—Alzheimer's disease	2.1e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EIF2AK2—Alzheimer's disease	2.1e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NPY—Alzheimer's disease	2.09e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IAPP—Alzheimer's disease	2.08e-05	0.000146	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GAPDH—Alzheimer's disease	2.06e-05	0.000145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—BCL2—Alzheimer's disease	2.05e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.03e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1A—Alzheimer's disease	2.02e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.02e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CRH—Alzheimer's disease	2.02e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MEF2C—Alzheimer's disease	1.96e-05	0.000138	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AGER—Alzheimer's disease	1.94e-05	0.000137	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—AKT1—Alzheimer's disease	1.94e-05	0.000136	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PSEN2—Alzheimer's disease	1.92e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PRKCG—Alzheimer's disease	1.92e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PPARG—Alzheimer's disease	1.92e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NPS—Alzheimer's disease	1.91e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PPP3CA—Alzheimer's disease	1.91e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL6—Alzheimer's disease	1.89e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.89e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—INS—Alzheimer's disease	1.88e-05	0.000132	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CST3—Alzheimer's disease	1.88e-05	0.000132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTK2B—Alzheimer's disease	1.88e-05	0.000132	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.87e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CHAT—Alzheimer's disease	1.87e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TPI1—Alzheimer's disease	1.87e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6—Alzheimer's disease	1.86e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SST—Alzheimer's disease	1.83e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GAB2—Alzheimer's disease	1.83e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NTRK2—Alzheimer's disease	1.83e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—LPL—Alzheimer's disease	1.82e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ACHE—Alzheimer's disease	1.82e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GSK3A—Alzheimer's disease	1.81e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—INPP5D—Alzheimer's disease	1.8e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MAOB—Alzheimer's disease	1.79e-05	0.000126	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APP—Alzheimer's disease	1.78e-05	0.000125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PRKCG—Alzheimer's disease	1.77e-05	0.000125	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IAPP—Alzheimer's disease	1.76e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GAPDH—Alzheimer's disease	1.72e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKT1—Alzheimer's disease	1.72e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ENO1—Alzheimer's disease	1.71e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.7e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.69e-05	0.000119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CCR5—Alzheimer's disease	1.68e-05	0.000118	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PLCB1—Alzheimer's disease	1.68e-05	0.000118	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP2D6—Alzheimer's disease	1.68e-05	0.000118	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—A2M—Alzheimer's disease	1.66e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.66e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MAPK8—Alzheimer's disease	1.66e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CALM1—Alzheimer's disease	1.66e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—NOS3—Alzheimer's disease	1.65e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTHFR—Alzheimer's disease	1.64e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ENO1—Alzheimer's disease	1.62e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PPP3CA—Alzheimer's disease	1.61e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—BCHE—Alzheimer's disease	1.59e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NGFR—Alzheimer's disease	1.57e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GAB2—Alzheimer's disease	1.55e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CALM1—Alzheimer's disease	1.53e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GSK3A—Alzheimer's disease	1.53e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADAM10—Alzheimer's disease	1.53e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOE—Alzheimer's disease	1.53e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CAV1—Alzheimer's disease	1.52e-05	0.000107	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—Alzheimer's disease	1.51e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APP—Alzheimer's disease	1.51e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PLCB1—Alzheimer's disease	1.5e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.48e-05	0.000104	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.47e-05	0.000103	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ABCA1—Alzheimer's disease	1.45e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ACHE—Alzheimer's disease	1.45e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—S100B—Alzheimer's disease	1.45e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—GSK3B—Alzheimer's disease	1.43e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—INPP5D—Alzheimer's disease	1.43e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS2—Alzheimer's disease	1.42e-05	0.0001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CREB1—Alzheimer's disease	1.42e-05	0.0001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOTCH1—Alzheimer's disease	1.41e-05	9.92e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.4e-05	9.88e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF2—Alzheimer's disease	1.38e-05	9.69e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ENO1—Alzheimer's disease	1.36e-05	9.54e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTGS1—Alzheimer's disease	1.36e-05	9.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1R—Alzheimer's disease	1.33e-05	9.37e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	1.33e-05	9.35e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—GSK3B—Alzheimer's disease	1.32e-05	9.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CREB1—Alzheimer's disease	1.31e-05	9.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—INS—Alzheimer's disease	1.31e-05	9.19e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ADAM10—Alzheimer's disease	1.29e-05	9.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LPL—Alzheimer's disease	1.28e-05	8.98e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MEF2C—Alzheimer's disease	1.27e-05	8.9e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—BCHE—Alzheimer's disease	1.26e-05	8.87e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARGC1A—Alzheimer's disease	1.25e-05	8.81e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HMOX1—Alzheimer's disease	1.25e-05	8.77e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRKCG—Alzheimer's disease	1.24e-05	8.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NGF—Alzheimer's disease	1.21e-05	8.51e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2—Alzheimer's disease	1.19e-05	8.4e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PLCB1—Alzheimer's disease	1.19e-05	8.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR5—Alzheimer's disease	1.18e-05	8.28e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCA1—Alzheimer's disease	1.15e-05	8.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HTR2A—Alzheimer's disease	1.15e-05	8.1e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS3—Alzheimer's disease	1.15e-05	8.06e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—LPL—Alzheimer's disease	1.14e-05	8.02e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—LPL—Alzheimer's disease	1.08e-05	7.6e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CALM1—Alzheimer's disease	1.07e-05	7.56e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LEP—Alzheimer's disease	1.07e-05	7.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOE—Alzheimer's disease	1.07e-05	7.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—Alzheimer's disease	1.06e-05	7.47e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CAV1—Alzheimer's disease	1.06e-05	7.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1B—Alzheimer's disease	1.06e-05	7.43e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PRKCG—Alzheimer's disease	1.05e-05	7.39e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—Alzheimer's disease	1.05e-05	7.37e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTHFR—Alzheimer's disease	1.03e-05	7.22e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ESR1—Alzheimer's disease	1.02e-05	7.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—F2—Alzheimer's disease	1.01e-05	7.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CCR5—Alzheimer's disease	9.96e-06	7e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	9.94e-06	6.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HMOX1—Alzheimer's disease	9.89e-06	6.96e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH1—Alzheimer's disease	9.88e-06	6.95e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—Alzheimer's disease	9.79e-06	6.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTHFR—Alzheimer's disease	9.73e-06	6.84e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK8—Alzheimer's disease	9.68e-06	6.81e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CALM1—Alzheimer's disease	9.59e-06	6.74e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOE—Alzheimer's disease	9.56e-06	6.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CAV1—Alzheimer's disease	9.47e-06	6.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—Alzheimer's disease	9.4e-06	6.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GSK3B—Alzheimer's disease	9.27e-06	6.52e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CREB1—Alzheimer's disease	9.2e-06	6.47e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—INS—Alzheimer's disease	9.15e-06	6.43e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CALM1—Alzheimer's disease	9.09e-06	6.39e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOE—Alzheimer's disease	9.06e-06	6.37e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LPL—Alzheimer's disease	9.05e-06	6.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL2—Alzheimer's disease	9e-06	6.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CAV1—Alzheimer's disease	8.97e-06	6.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1—Alzheimer's disease	8.85e-06	6.22e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS2—Alzheimer's disease	8.44e-06	5.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOTCH1—Alzheimer's disease	8.36e-06	5.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARG—Alzheimer's disease	8.32e-06	5.85e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—INS—Alzheimer's disease	8.16e-06	5.74e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTHFR—Alzheimer's disease	8.15e-06	5.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOS3—Alzheimer's disease	8.02e-06	5.64e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GSK3B—Alzheimer's disease	7.84e-06	5.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CREB1—Alzheimer's disease	7.78e-06	5.47e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—INS—Alzheimer's disease	7.74e-06	5.44e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CALM1—Alzheimer's disease	7.61e-06	5.35e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—Alzheimer's disease	7.59e-06	5.34e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOE—Alzheimer's disease	7.59e-06	5.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—Alzheimer's disease	7.58e-06	5.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CAV1—Alzheimer's disease	7.52e-06	5.29e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NOS3—Alzheimer's disease	7.16e-06	5.03e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP3—Alzheimer's disease	6.81e-06	4.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS3—Alzheimer's disease	6.79e-06	4.77e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARG—Alzheimer's disease	6.61e-06	4.65e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—Alzheimer's disease	6.55e-06	4.6e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—INS—Alzheimer's disease	6.48e-06	4.56e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK8—Alzheimer's disease	6.26e-06	4.4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—Alzheimer's disease	6.18e-06	4.35e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—Alzheimer's disease	5.78e-06	4.06e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—Alzheimer's disease	5.71e-06	4.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—Alzheimer's disease	5.7e-06	4.01e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NOS3—Alzheimer's disease	5.68e-06	4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—Alzheimer's disease	5.3e-06	3.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—Alzheimer's disease	5.27e-06	3.7e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—Alzheimer's disease	4.49e-06	3.16e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—Alzheimer's disease	4.37e-06	3.07e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—Alzheimer's disease	4e-06	2.81e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—Alzheimer's disease	3.69e-06	2.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—Alzheimer's disease	3.38e-06	2.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—Alzheimer's disease	3.29e-06	2.31e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—Alzheimer's disease	3.12e-06	2.19e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—Alzheimer's disease	2.61e-06	1.84e-05	CbGpPWpGaD
